Top Markets
Coin of the day
Taro Pharmaceutical Industries Ltd. Taro Pharmaceutical Industries Ltd.

Taro Pharmaceutical Industries Ltd.

TARO
Clasificación en acciones #7357
Taro Pharmaceutical Industries Ltd. operates as a scientifically-driven... Taro Pharmaceutical Industries Ltd. operates as a scientifically-driven pharmaceutical enterprise, specializing in the development, manufacturing, and commercialization of both prescription and over-the-counter medications. Its market reach spans the United States, Canada, Israel, and various other international territories. The company also produces active pharmaceutical ingredients (APIs), primarily for integration into its own finished dosage form products. Its extensive product catalog addresses a broad spectrum of medical conditions and therapeutic areas, encompassing treatments for allergies, pain (analgesic), bacterial and fungal infections (antibacterial, antibiotic, antifungal), seizures (anticonvulsant), nausea (antiemetic), inflammation (anti-inflammatory), cancer (anti-cancer, topical anti-neoplastic), blood clot prevention (antiplatelet agent), fever reduction (antipyretic), cardiovascular issues, central nervous system disorders, hormonal regulation (corticosteroid, endocrine), cosmetic applications, coughs and colds, dermatological complaints, fluid management (diuretic), gastrointestinal problems, constipation (laxative), severe pain (narcotics), neuropathic pain, neuropsychiatric conditions, and sleep/anxiety management (sedative/hypnotic). These pharmaceutical goods are available in numerous formats, including capsules, creams, drops, emulsions, gels (and gel kits), granules, injectables, lotions, oils, ointments, pastes, powders (and powders for solution), rectal suppositories, shampoos, solutions (and solutions for infusion), sprays, suspensions, syrups, tablets, toothpastes and mouthwashes, topical foams, and topical solutions. Taro distributes and sells its products directly to a wide array of clients, such as pharmaceutical wholesalers, retail drug store chains, food chains, hospitals, mass merchandisers, grocery chains, other direct purchasers, and various healthcare institutions and private pharmacies. The company was established in 1950, with its main offices situated in Haifa, Israel. Taro Pharmaceutical Industries Ltd. is a wholly-owned subsidiary of Alkaloida Chemical Company Exclusive Group Ltd.
Precio por acción
$42.98
Última sincronización: 2024-06-21
Capitalización bursátil
$1.62B
Cambio (1 día)
0.01%
Cambio (1 año)
0.00%
País
IL
Comercio Taro Pharmaceutical Industries Ltd. (TARO)

Categoría

Margen Operativo de Taro Pharmaceutical Industries Ltd. (TARO)
Margen Operativo al August 2026 TTM: 3.42%
Según los informes financieros más recientes y el precio de las acciones de Taro Pharmaceutical Industries Ltd., el margen operativo actual (TTM) es 3.42%. Al final de 2023, el margen operativo era 3.09%.
Historial de Margen Operativo de Taro Pharmaceutical Industries Ltd. desde 1999 hasta 2026
Margen Operativo al final de cada año
Año Margen Operativo Cambiar
2026 (TTM) 3.42% 0.00%
2024 3.42% 10.68%
2023 3.09% -90.59%
2022 32.84% -74.41%
2021 128.32% 235.56%
2020 38.24% -13.50%
2019 44.21% -3.43%
2018 45.78% -21.82%
2017 58.56% -9.39%
2016 64.63% 5.71%
2015 61.14% 7.89%
2014 56.67% 15.72%
2013 48.97% 12.32%
2011 43.60% 97.91%
2010 22.03% 24.96%
2009 17.63% 32.46%
2008 13.31% -27.98%
2007 18.48% -166.26%
2006 -27.89% -646.86%
2005 5.10% -2,933.33%
2004 -0.18% -100.76%
2003 23.68% -5.92%
2002 25.17% 15.30%
2001 21.83% 40.75%
2000 15.51% 20.23%
1999 12.90% 0.00%
Margen Operativo de empresas similares o competidoras
Empresa Margen Operativo Diferencia de Margen Operativo País
0.00% -
DE
0.00% -
DE
0.00% -
JP
0.00% -
CH
22.93% -93.30%
IN
¿Qué es el Margen Operativo de una empresa?
El Margen Operativo es un indicador clave para evaluar la rentabilidad de una empresa. Un margen operativo más alto suele ser mejor, ya que indica que una empresa puede vender sus productos o servicios por mucho más de lo que cuestan producirlos. Se calcula dividiendo las ganancias de la empresa entre sus ingresos.